Kill the rumors or lose the battle
In mid-April, Minister Pierre Dimba, who had just been appointed Minister of Health, made the same observation: fake news is spreading on social media, discouraging people from getting the vaccine and undermining the vaccination campaign in Côte d’Ivoire. For his part, Professor Mamadou Samba, Director General of Health, kept repeating the same reassuring scientific facts: “We have not recorded any cases of serious side effects from the AstraZeneca vaccine. This vaccine is very safe and is being used in many countries.” But he was confronted by a wall of mistrust that had been built up in working-class circles and even among young professionals, although they were expected to be relaying awareness messages to the general public.
In the immediate future, tens of thousands of Ivorians had to be convinced of the effectiveness of the vaccines and, above all, the wild rumors about the harmful and even fatal side effects of the AstraZeneca vaccine had to be squelched. Minister Dimba began holding conversations with key players at the national level and with international organizations, and enlisted as many people as he could to get the word out, including social media influencers, religious and community leaders, and local elected officials. For Pierre Dimba, “the survival of our population is at stake and by stepping up vaccination campaigns in markets and places of worship, we hope to quickly reach the goal of vaccinating nearly six million people throughout the country.”
The government has also begun expanding the vaccination campaign in the rest of the country. It has deployed mobile clinics—large medically equipped buses that travel to the busiest areas to educate, mobilize, and vaccinate people. This new strategy requires significant financial and logistical resources, and for this Côte d’Ivoire can count on an important partner.
The awareness-raising campaign launched by the government to address low vaccine uptake among the population has enabled Côte d’Ivoire to boost vaccination rates. © Erick Kaglan, World Bank.
An international leader in the fight against COVID-19
In April, the World Bank, which had already committed more than $75 million to the fight against COVID-19 in Côte d’Ivoire, provided a further $100 million in funding to the Ivorian government through the International Development Association (IDA). The goal is to facilitate the acquisition of new vaccines against COVID-19 and reinforce the national vaccination campaign in order to limit the spread of coronavirus.
This additional funding, which is part of the COVID-19 Strategic Preparedness and Response Project, is intended to enable Côte d’Ivoire to diversify its vaccine supply sources, ensure effective deployment at the national level, and support awareness-raising efforts. It has made it possible to cover the logistical costs and scaling up the campaign, in particular through the roll out in the country’s 113 health districts and the operation of 12 mobile clinics in Abidjan.
At the same time, the World Bank’s health and communication specialists are working alongside government teams to bolster the community mobilization campaign and step-up communication about the vaccine.
Demand soared, making Côte d’Ivoire an international model for successful management of the antivax movement. “Now, our center is overrun in the morning and we vaccinate at least 300 people a day,” says Dr. Adèle Telly, head of the COVID-19 center at the Treichville sports center. As of early July, the country had more than 300 fixed and mobile vaccination sites.
But while the awareness-raising campaign is bearing fruit and demand for vaccines is rising, the government has had to grapple with vaccine shortage and overall limited supply on the continent.